Hahn, Felix
Müller, Lukas
Jungmann, Florian
Mähringer-Kunz, Aline
Tanyildizi, Yasemin
Düber, Christoph
Galle, Peter R.
Weinmann, Arndt
Kloeckner, Roman http://orcid.org/0000-0001-5492-4792
Article History
Received: 6 January 2020
Accepted: 24 March 2020
First Online: 30 March 2020
Compliance with ethical standards
:
: PRG has received grants and personal fees from Bayer and personal fees from Bristol-Myers Squibb, MSD Sharp & Dohme, Lilly, Sillajen, SIRTEX, and AstraZeneca. AW has received speaker fees and travel grants from Bayer. RK has received speaker fees from BTG, Guerbet, and SIRTEX and personal fees from Boston Scientific, Bristol-Myers Squibb, Guerbet, and SIRTEX. None of these companies supported this study, and none of the authors reports a conflict of interest.
: The study was approved by the responsible ethics committee (Ethics committee of the Medical Association of Rhineland Palatinate, Mainz, Germany) for the retrospective analysis of clinical data (permit number 2018–13618). Additional examinations were not performed. Patient records and information were anonymized and de-identified prior to analysis.